The largest database of trusted experimental protocols

Poly 1 c

Manufactured by Merck Group
Sourced in United States, Germany, United Kingdom, France, China, Switzerland, Canada, Sao Tome and Principe, Israel, Japan, Italy, Spain

Poly(I:C) is a synthetic double-stranded RNA (dsRNA) molecule that mimics the structure of viral RNA. It is used as a research tool in various applications, such as the study of innate immune responses and the development of antiviral therapies. Poly(I:C) can activate specific cellular pathways and signaling cascades, making it a valuable reagent for in vitro and in vivo experiments.

Automatically generated - may contain errors

527 protocols using poly 1 c

1

Perinatal Poly I:C Exposure in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
The solution of Poly I:C (Sigma-Aldrich, St. Louis, MO, USA) in saline at a concentration of 3 mg/kg in 1 mL was administered intraperitoneally [131 (link)] to male offspring from the control + Poly I:C, MIAPPI-low + Poly I:C and MIAPPI-high + Poly I:C groups at PND120. The control + vehicle, MIAPPI-low + vehicle, and MIAPPI-high + vehicle groups received an appropriate injection of vehicle (saline).
+ Open protocol
+ Expand
2

Poly I:C Immune Activation in Tsc2+/- Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
To test the impact of immune activation during early postnatal development on Tsc2+/− mice, we first crossed male Tsc2+/− mice (62 (link)) with female WT mice. Tsc2+/− male breeders were on a C57BL/6Ncrl genetic background (Charles River Laboratories, catalog no. 027). We used C57BL/6J females [the Jackson Laboratory (JAX), catalog no. 000664] to generate experimental mice. Pregnant females were single-housed and left undisturbed except for weekly cage changes. Pregnancy was determined by checking for abdominal distension. For all the mice studied here, pregnant females were checked every day to determine the exact day when the pups were born (designated as P0). Pups were injected intraperitoneally with either Poly I:C (20 mg/kg; Sigma-Aldrich, St. Louis, MO, USA; potassium salt; Poly I:C is supplied at 10% of the total weight of the salt; dosage was based on the weight of Poly I:C itself) or vehicle only (0.9% sterile saline) at P3, P7, and P14. To test the effect of immune activation in adult Tsc2+/− mutants, adult WT and mutant mice were injected three times with Poly I:C (20 mg/kg) following a similar relative schedule as that used during early postnatal development. Tail biopsies for genotyping were taken around P40.
+ Open protocol
+ Expand
3

Dendritic Cell Maturation Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
On Day 5, immature MoDCs were cultured with or without 100 ng/ml lipopolysaccharide (LPS) or 30 µg/ml polyinosinic polycytidylic acid (Poly I:C) (Sigma-Aldrich, Gillingham, UK), in the absence or presence of 1% or 3% ECVE, at 37 °C, 5% CO2 for 24 h. The cells treated with LPS or Poly I:C for 24 h (with or without simultaneous treatment with ECVE) are referred to as ‘LPS-matured DCs’ or ‘Poly I:C-matured DCs’, respectively.
+ Open protocol
+ Expand
4

Isolation and Culture of Microglia and Astrocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were dissociated from the cortices, plated on flasks, and cultivated in minimum essential medium (MEM, Fisher Scientific) supplemented with 10% FBS (Fisher Scientific) and 1% penicillin-streptomycin (Fisher Scientific) at 37 °C. After 12-14 d of culture, mature microglia were separated from mixed glial cultures by quick and gentle shaking, resuspended in MEM supplemented with 3% FBS, and plated onto plates. The remaining mixed glial cells were passaged 2-3 times and shaken at 200 r.p.m. for 6 h. The supernatants were discarded and the remaining adherent cells were collected as astrocytes. Cells were allowed to settle down for 2-3 h for further experiments. For drug treatments, microglia were incubated with LPS or poly(I:C) (Sigma) for different time periods as indicated. To scavenge mitochondrial superoxide, 250 μM Mito-TEMPO (Sigma) was added to medium 1 h before LPS/ poly(I:C) stimulation.
+ Open protocol
+ Expand
5

Amphioxus DExD/H Helicase Expression Pattern

Check if the same lab product or an alternative is used in the 5 most similar protocols
To test the expression pattern of amphioxus DExD/H helicases upon poly(I:C) stimulation, the primary amphioxus intestine cells were transfected with poly(I:C) (Sigma-Aldrich) at a final concentration of 3 μg/ml and collected at 0, 2, 4, 6, 12, and 24 h post-poly(I:C) transfection. Then qRT-PCR assays were conducted using primer pairs:
BbeDHX9-F: 5′GACTACCAGGAATACTTTGAG3′
BbeDHX9-R: 5′CACCACATGATGCTCCACCTT3′
BbeDHX15-F: 5′GGTCGTGGTGTCTACTAACAT3′
BbeDHX15-R: 5′GGTACGTCTGGTCCTGCATCT3′
BbeDDX23-F: 5′CCCAGCAGATCGAGGAGGAGA3′
BbeDDX23-R: 5′CACATCTGGCTCGAAACCCAT3′
+ Open protocol
+ Expand
6

Macrophage and B-cell Response to HgCl2 and Poly I:C

Check if the same lab product or an alternative is used in the 5 most similar protocols
For most of the assays, either HD‐11 macrophages or DT40 B‐cells were seeded at a density of 1 × 105 cells/well in a clear, flat‐bottomed 96‐well plate and incubated overnight before exposure. In proliferation assays, 1 × 104 cells/well were seeded, allowing a longer exposure time (48 h). For RT‐qPCR, 1 × 106 cells/well were seeded in 12‐well plates. A series of HgCl2 (Sigma‐Aldrich) stock solutions ranging from 0.2 to 2000 µM were prepared in sterile Milli‐Q water and diluted 20 times in culture medium to the final exposure concentration, ranging from 0.01 to 100 µM. Then 5 mg/ml poly I:C stock solution was prepared in PBS and stored at –20 °C. To activate the cells, poly I:C (Sigma‐Aldrich) stock solution was diluted 200 times in culture medium to a final concentration of 25 µg/ml in all assays. Also, to block de novo GSH synthesis via γ‐glutamylcysteine synthetase, 200 µM (final concentration) of BSO was added to the culture medium of the cells in the cytotoxicity, GSH, ROS, and nitric oxide assays. Exposure to HgCl2, poly I:C, and BSO started at the same time. Exposure time was 24 h for most assays, except for the proliferation assays, in which the exposure time was prolonged to 48 h.
+ Open protocol
+ Expand
7

Immune Response in Golden Pompanos

Check if the same lab product or an alternative is used in the 5 most similar protocols
Healthy golden pompanos (250 ± 15.2 g) were kept in the running seawater at 26 ± 2°C in our laboratory for at least 2 weeks before experiments. The fishes were randomly divided into four groups (30 fishes per group): LPS challenge group, poly I:C challenge group, Vibrio alginolyticus challenge group and control group, among which the fishes were intraperitoneally (i.p) injected with LPS (100 μg per 100 g fish, Sigma, USA), poly I:C (100 μg per 100 g fish, Sigma, USA), 5×107 CFU live V. alginolyticus (100 μL per 100 g fish, TSTO, China) and same amount of PBS solution, respectively. The head kidney (HK), spleen, liver, intestine and gill were collected from five fishes in each group at 0 h, 6 h, 12 h, 24 h, and 48 h post-injection (hpi). In addition, tissues including spleen, HK, skin, muscle, gill, heart, liver, brain and intestine were respectively collected from five healthy fishes. All tissues were immediately frozen in liquid nitrogen and stored at −80°C until use.
+ Open protocol
+ Expand
8

Maternal Immune Activation and NAC Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
MIS model: On gestational day 15 (GD15), Poly I:C (4 mg/kg, Sigma-Aldrich, Madrid, Spain) or saline solution was administered i.v. to pregnant Wistar rats. This protocol is associated with a high risk of the onset of behavioral and neurological deficits in the offspring at adulthood, similar to those found in patients with SCZ [11 (link),14 (link)]. On post-natal day (PND) 21, male-offspring were weaned and housed 2–4 per cage. Females were not studied because they do not reproduce the well-characterized SCZ-like deficits in males of the MIS model at PND100 [32 (link)].
NAC treatment during gestation: NAC (500 mg/kg, Sigma-Aldrich, Madrid, Spain) diluted in drinking water (VH) was administered at two different time periods during gestation: throughout gestation (NAC21, 21 days of administration) or after the Poly I:C/saline administration (NAC7, 7 days of administration, from gestational days 15 to 21). Water intake was monitored to calculate the dose of NAC ingested by animals and freshly prepared to prevent NAC degradation. The dose of NAC ingested daily by each animal was similar in all groups (minimum dose: 518 mg/kg, maximum dose: 552 mg/kg).
Animals were divided into six groups (6–12 animals per group) according to the factors of the study: phenotype (Saline, MIS) and treatment (water without NAC, water with NAC for 7 days–NAC7, water with NAC for 21 days–NAC21).
+ Open protocol
+ Expand
9

Modeling Neurodevelopmental Disorder via MIA

Check if the same lab product or an alternative is used in the 5 most similar protocols
At 12.5 dpc, dams were administered an i.p. injection of poly (I:C) (Sigma Aldrich, St. Louis, MO) at 4 mg/kg or 20 mg/kg based on the weight of the poly (I:C) itself [8 (link)]. A model of neurodevelopmental disorder using MIA resulted in severe MIA equivalent to fulminant infection in human [8 (link), 10 (link), 18 (link)–20 (link)]. In clinical settings, all the infected mothers would not suffer from fulminant infection. Therefore, we also examined the effects of comparatively low dose of poly (I:C). In this study, the groups injected with poly (I:C) at 4 mg/kg or 20 mg/kg are presented as Poly 4 and Poly 20, respectively. We injected intraperitoneally mouse recombinant LIF (rLIF; Millipore, Billerica, MA) into dams at 5 μg/kg body weight [14 (link)] at 12.5 or 13.5 dpc. The injection volume was unified into 0.01 ml/g. Control was injected with 0.01 ml/g volume of only saline.
+ Open protocol
+ Expand
10

Cytokine Stimulation of Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded at 7 × 103 cells/cm2 and treated for 24 hours with increasing doses of recombinant human HMGB-1 (1–200 ng/ml), IL-1α (25–1000 pg/ml), IL-1β (25–1000 pg/ml) (all R&D), LPS (0.1–20 μg/ml) and PolyIC (0.1–20 μg/ml) (both Sigma) or for 24 hours with LPS (5 μg/ml), PolyIC (5 μg/ml), HMGB-1 (50 ng/ml), IL-1α (500 pg/ml) and IL-1β (500 pg/ml) alone or in combination. Cell culture supernatants were harvested for ELISA. For PCR, cells were seeded at 7 × 103 cells/cm2 and treated for 48 hours with TGF-β1 (3 ng/ml).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!